Abstract
Resveratrol is a phenol compound produced by some plants in response to pathogens, infection, or physical injury. It is well-known that resveratrol has antioxidant and protective roles in damages potentially caused by cancer or other serious disorders. Thus, it is considered as a candidate agent for the prevention and treatment of human diseases. Evidence has confirmed other bioactive impacts of resveratrol, including cardioprotective, anti-tumorigenic, anti-inflammatory, phytoestrogenic, and neuroprotective effects. Ischemia–reperfusion (IR) can result in various disorders, comprising myocardial infarction, stroke, and peripheral vascular disease, which may continue to induce debilitating conditions and even mortality. In virtue of chronic ischemia or hypoxia, cells switch to anaerobic metabolism, giving rise to some dysfunctions in mitochondria. As the result of lactate accumulation, adenosine triphosphate levels and pH decline in cells. This condition leads cells to apoptosis, necrosis, and autophagy. However, restoring oxygen level upon reperfusion after ischemia by producing reactive oxygen species is an outcome of mitochondrial dysfunction. Considering the neuroprotective effect of resveratrol and neuronal injury that comes from IR, we focused on the mechanism(s) involved in IR injury in the nervous system and also on the functions of resveratrol in the protection, inhibition, and treatment of this injury.
Similar content being viewed by others
References
Nance JR, Golomb MR (2007) Ischemic spinal cord infarction in children without vertebral fracture. Pediatr Neurol 36:209–216
Nour M, Scalzo F, Liebeskind DS (2012) Ischemia-reperfusion injury in stroke. Interv Neurol 1:185–199
Carden DL, Granger DN (2000) Pathophysiology of ischaemia–reperfusion injury. J Pathol 190:255–266
Elshiekh M et al (2015) Ameliorative effect of recombinant human erythropoietin and ischemic preconditioning on renal ischemia reperfusion injury in rats. Nephro-urology Monthly. https://doi.org/10.5812/numonthly.31152
Seifi B et al (2015) Angiotensin II in paraventricular nucleus contributes to sympathoexcitation in renal ischemia–reperfusion injury by AT1 receptor and oxidative stress. J Surg Res 193:361–367
Ramírez-Garza S et al (2018) Health effects of resveratrol: Results from human intervention trials. Nutrients 10:1892
Yu W, Fu YC, Wang W (2012) Cellular and molecular effects of resveratrol in health and disease. J Cell Biochem 113:752–759
Bertelli AA, Das DK (2009) Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 54:468–476
Rafiei RM et al (2011) The effect of grape seed extract on lipid peroxidation duo to ischemia/hypoperfusion in male rat striatum. J Anim Biol 3:37–44
Walle T et al (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382
Salehi B et al (2018) Resveratrol: a double-edged sword in health benefits. Biomedicines 6:91
Wenzel E, Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472–481
Amri A et al (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158:182–193
Neves AR et al (2013) Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Nanomed 8:177
Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493
Rauf A et al (2017) A comprehensive review of the health perspectives of resveratrol. Food Funct 8:4284–4305
Katan M, Luft A (2018) Global burden of stroke. In seminars in neurology. Thieme Medical Publishers, New York
Shen M et al (2012) Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS ONE. https://doi.org/10.1371/journal.pone.0051223
Mao Z-J et al (2019) A Meta-Analysis of resveratrol protects against myocardial ischemia/reperfusion injury: evidence from small animal studies and insight into molecular mechanisms. Oxid Med Cell Longev. https://doi.org/10.1155/2019/5793867
Hascalik S et al (2004) Resveratrol, a red wine constituent polyphenol, protects from ischemia-reperfusion damage of the ovaries. Gynecol Obstet Investig 57:218–223
Liu F-C, Tsai H-I, Yu H-P (2015) Organ-protective effects of red wine extract, resveratrol, in oxidative stress-mediated reperfusion injury. Oxid Med Cell Longev. https://doi.org/10.1155/2015/568634
Ghosh N et al (2014) Advances in herbal medicine for treatment of ischemic brain injury. Nat Prod Commun. 9:1045–1055
Tomé-Carneiro J et al (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19:6064–6093
Wu M-Y et al (2018) Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46:1650–1667
Collard CD, Gelman S (2001) Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 94:1133–1138
Eltzschig HK, Collard CD (2004) Vascular ischaemia and reperfusion injury. Br Med Bull 70:71–86
Tachibana M et al (2017) Early reperfusion after brain ischemia has beneficial effects beyond rescuing neurons. Stroke 48:2222–2230
Sanderson TH et al (2013) Molecular mechanisms of ischemia–reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 47:9–23
Molina CA (2011) Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 42:S16–S19
Lin L, Wang X, Yu Z (2016) Ischemia-reperfusion injury in the brain: mechanisms and potential therapeutic strategies. Biochem Pharmacol Open Access. https://doi.org/10.4172/2167-0501.1000213
Wang Y et al (2018) Protecting neurons from cerebral ischemia/reperfusion injury via nanoparticle-mediated delivery of an siRNA to inhibit microglial neurotoxicity. Biomaterials 161:95–105
White BC et al (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1–33
Zhuang H et al (2003) Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci 993:276–286
Albani D et al (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. BioFactors 36:370–376
Bhat KP, Kosmeder JW, Pezzuto JM (2001) Biological effects of resveratrol. Antioxid Redox Signal 3:1041–1064
Lopez MS, Dempsey RJ, Vemuganti R (2015) Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int 89:75–82
Pallàs M et al (2009) Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6:70–81
Della-Morte D et al (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1–uncoupling protein 2 pathway. Neuroscience 159:993–1002
Kesherwani V et al (2013) Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience 241:80–88
Khan MM et al (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Res 1328:139–151
Yiu EM et al (2015) An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels. J Neurol 262:1344–1353
Agrawal M et al (2011) Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. Eur J Pharmacol 666:5–11
Kanthasamy K et al (2011) Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity. Curr Neuropharmacol 9:49–53
Qian C et al (2017) SIRT1 activation by resveratrol reduces brain edema and neuronal apoptosis in an experimental rat subarachnoid hemorrhage model. Mol Med Rep 16:9627–9635
Feng X et al (2013) Resveratrol inhibits β-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS ONE. https://doi.org/10.1371/journal.pone.0059888
Bai T, Dong D-S, Pei L (2013) Resveratrol mitigates isoflurane-induced neuroapoptosis by inhibiting the activation of the Akt-regulated mitochondrial apoptotic signaling pathway. Int J Mol Med 32:819–826
Hu W et al (2018) Resveratrol protects neuronal cells from isoflurane-induced inflammation and oxidative stress-associated death by attenuating apoptosis via Akt/p38 MAPK signaling. Exp Ther Medi 15:1568–1573
Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221:3–12
Sarkaki A et al (2015) Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia. Metab Brain Dis 30:1139–1150
Lin T-K et al (2014) Resveratrol partially prevents rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through induction of heme oxygenase-1 dependent autophagy. Int J Mol Sci 15:1625–1646
Hu J et al (2017) Resveratrol improves neuron protection and functional recovery through enhancement of autophagy after spinal cord injury in mice. Am J Transl Res 9:4607
Wu Y et al (2011) Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease. Neurosignals 19:163–174
Guo D et al (2018) Resveratrol protects early brain injury after subarachnoid hemorrhage by activating autophagy and inhibiting apoptosis mediated by the Akt/mTOR pathway. NeuroReport 29:368
Stephenson J et al (2018) Inflammation in CNS neurodegenerative diseases. Immunology 154:204–219
Gatson JW et al (2013) Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury. J Trauma Acute Care Surg 74:470–475
Im Jeong S et al (2016) Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice. Neurobiol Aging 44:74–84
Li X-M et al (2014) Resveratrol pretreatment attenuates the isoflurane-induced cognitive impairment through its anti-inflammation and-apoptosis actions in aged mice. J Mol Neurosci 52:286–293
Liu C et al (2011) Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 1374:100–109
Li D et al (2017) Protective effect of resveratrol against nigrostriatal pathway injury in striatum via JNK pathway. Brain Res 1654:1–8
Broussalis E et al (2012) Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention. Drug Discov Today 17:296–309
Alberts MJ, Ovbiagele B (2007) Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol 254:1414–1426
Moretti A, Ferrari F, Villa RF (2015) Neuroprotection for ischaemic stroke: current status and challenges. Pharmacol Ther 146:23–34
Falahieh KH et al (2020) Ellagic acid attenuates post-cerebral ischemia and reperfusion behavioral deficits by decreasing brain tissue inflammation in rats. Iran J Basic Med Sci 23:645
Gaire BP (2018) Herbal Medicine in ischemic stroke: challenges and prospective. Chin J Integr Med 24:243–246
Gu Y, Chen J, Shen J (2014) Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J Neuroimmune Pharmacol 9:313–339
Berman AY et al (2017) The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol 1:35
Faggi L et al (2018) Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. Int J Mol Sci 19:172
Ishrat T et al (2015) Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol 51:766–778
Clark D et al (2012) Protection against recurrent stroke with resveratrol: endothelial protection. PLoS ONE. https://doi.org/10.1371/journal.pone.0047792
Shin JA et al (2010) Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J Neuroimmunol 227:93–100
Wan D et al (2016) Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res Bull 121:255–262
Yu P et al (2017) Resveratrol pretreatment decreases ischemic injury and improves neurological function via sonic hedgehog signaling after stroke in rats. Mol Neurobiol 54:212–226
Giarretta I et al (2020) Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo. J Cerebral Blood Flow Metab 41(2):324–335
Chen J et al (2016) Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs. Acta Neurol Scand 134:54–60
Fodor K et al (2018) Long-Term Resveratrol supplementation as a secondary prophylaxis for stroke. Oxid Med Cell Longev. https://doi.org/10.1155/2018/4147320
Heimer L (2012) The human brain and spinal cord: functional neuroanatomy and dissection guide. Springer, New York
Korani MS et al (2014) Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats. Eur J Pharmacol 733:62–67
Yang G-Y, Betz AL (1994) Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658–1664
Kuroda S, Siesjö B (1997) Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci (New York, NY) 4:199–212
Aronowski J, Strong R, Grotta JC (1997) Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cerebral Blood Flow Metab 17:1048–1056
Ashabi G et al (2015) Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis 30:747–754
Kizmazoglu C et al (2015) Neuroprotective effect of resveratrol on acute brain ischemia reperfusion injury by measuring annexin V, p53, Bcl-2 levels in rats. J Korean Neurosurg Soc 58:508
He Q et al (2017) Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction. Int Immunopharmacol 50:208–215
Dou Z et al (2019) Neuroprotection of resveratrol against focal cerebral ischemia/reperfusion injury in mice through a mechanism targeting gut-brain axis. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-019-00687-3
Wiginton JG IV et al (2019) Spinal cord reperfusion injury: case report, review of the literature, and future treatment strategies. Cureus. https://doi.org/10.7759/cureus.527910.7759/cureus.5279
Antwi P et al (2018) “White cord syndrome” of acute hemiparesis after posterior cervical decompression and fusion for chronic cervical stenosis. World Neurosurg 113:33–36
Manzanero S, Santro T, Arumugam TV (2013) Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury. Neurochem Int 62:712–718
Al Dera H (2017) Neuroprotective effect of resveratrol against late cerebral ischemia reperfusion induced oxidative stress damage involves upregulation of osteopontin and inhibition of interleukin-1beta. J Physiol Pharmacol 68:47–56
Fang L et al (2015) Resveratrol alleviates nerve injury after cerebral ischemia and reperfusion in mice by inhibiting inflammation and apoptosis. Int J Clin Exp Med 8:3219
Ren J et al (2011) Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 36:2352
Fu S et al (2018) Resveratrol, an antioxidant, protects spinal cord injury in rats by suppressing MAPK pathway. Saudi J Biol Scie 25:259–266
Sakata Y et al (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224:325–329
Araujo JA, Zhang M, Yin F (2012) Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol 3:119
Paine A et al (2010) Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80:1895–1903
Ighodaro O, Akinloye O (2018) First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 54:287–293
Tayfur K, Koramaz İ (2020) The effect of combined resveratrol and nitric oxide treatment on the prevention of spinal cord ischemia-reperfusion injury: an experimental study. Turkish J Vasc Surg 29:1–6
Yang H et al (2016) Resveratrol pretreatment protected against cerebral ischemia/reperfusion injury in rats via expansion of T regulatory cells. J Stroke Cerebrovasc Dis 25:1914–1921
Liesz A et al (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15:192
Sakaguchi S et al (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21:1105–1111
Li W et al (2015) Resveratrol ameliorates oxidative stress and inhibits aquaporin 4 expression following rat cerebral ischemia-reperfusion injury. Mol Med Rep 12:7756–7762
Kiziltepe U et al (2004) Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40:138–145
Jiang L et al (2017) Roles of the Nrf2/HO-1 pathway in the anti-oxidative stress response to ischemia-reperfusion brain injury in rats. Eur Rev Med Pharmacol Sci 21:1532–1540
Abdel-Aleem GA et al (2016) Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway. Arch Physiol Biochem 122:200–213
Clements CM et al (2006) DJ-1, a cancer-and Parkinson’s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci 103:15091–15096
Malhotra D et al (2008) Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 178:592–604
Lu X et al (2020) Reperfusion combined with intraarterial administration of resveratrol-loaded nanoparticles improved cerebral ischemia–reperfusion injury in rats. Nanomed Nanotechnol Biol Med 28:102–208
Slevin M et al (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci 111:171–183
Beck H, Plate KH (2009) Angiogenesis after cerebral ischemia. Acta Neuropathol 117:481–496
Fan Y, Yang G-Y (2007) Therapeutic angiogenesis for brain ischemia: a brief review. J Neuroimmune Pharmacol 2:284–289
Kusaka N et al (2005) Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103:882–890
Bellomo M et al (2003) Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res 48:309–317
Dong W et al (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 48:709–714
Mizushima N (2007) Autophagy: process and function. Genes Dev 21:2861–2873
Mizushima N et al (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069
Zhang X et al (2013) Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 9:1321–1333
Sadoshima J (2008) The role of autophagy during ischemia/reperfusion. Autophagy 4:402–403
Li H et al (2014) Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood–brain barrier integrity during experimental cerebral ischemia–reperfusion injury. Transl Stroke Res 5:618–626
Chiu H-W et al (2016) Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy. J Mol Med 94:809–819
Chang YP et al (2015) Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy. J Cell Physiol 230:1567–1579
Wu J et al (2016) The role of resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS. Exp Cell Res 341:42–53
Dorweiler B et al (2007) Ischemia-reperfusion injury. Eur J Trauma Emerg Surg 33:600–612
Eefting F et al (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61:414–426
Zhao Z-Q et al (2000) Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45:651–660
Lam TT, Abler AS, Tso M (1999) Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Investig Ophthalmol Vis Sci 40:967–975
Jahangiri HM et al (2020) Gallic acid affects blood-brain barrier permeability, behaviors, hippocampus local EEG, and brain oxidative stress in ischemic rats exposed to dusty particulate matter. Environ Sci Pollut Res 27:5281–5292
Chen X et al (2012) Ischemia–reperfusion impairs blood–brain barrier function and alters tight junction protein expression in the ovine fetus. Neuroscience 226:89–100
Suzuki Y, Nagai N, Umemura K (2016) A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia. Front Cell Neurosci 10:2
Yang and A. Lorris Betz, (1994) Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658–1664
Khoshnam SE et al (2018) Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion. Metab Brain Dis 33:785–793
Rosenberg G, Estrada E, Dencoff J (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189–2194
Fujimura M et al (1999) Early appearance of activated matrix metalloproteinase-9 and blood–brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842:92–100
Wei H et al (2015) Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats. J Mol Neurosci 55:872–879
Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283
Orsu P, Murthy B, Akula A (2013) Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats. J Neural Transm 120:1217–1223
Girbovan C, Plamondon H (2015) Resveratrol downregulates type-1 glutamate transporter expression and microglia activation in the hippocampus following cerebral ischemia reperfusion in rats. Brain Res 1608:203–214
Chang C et al (2018) Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK/ERK/STAT signaling pathway in rats. J Neuroimmunol 315:9–14
Li Z et al (2016) Resveratrol protects CA1 neurons against focal cerebral ischemic reperfusion-induced damage via the ERK-CREB signaling pathway in rats. Pharmacol Biochem Behav 146:21–27
Lin Y et al (2013) Neuroprotective effect of resveratrol on ischemia/reperfusion injury in rats through TRPC6/CREB pathways. J Mol Neurosci 50:504–513
Wang Q et al (2006) Apocynin protects against global cerebral ischemia–reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090:182–189
Liu S, Sun J, Li Y (2016) The neuroprotective effects of resveratrol preconditioning in transient global cerebral ischemia-reperfusion in mice. Turk Neurosurg 26:550–555
Gao D et al (2006) Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia–reperfusion in mice. Life Sci 78:2564–2570
Kaplan S et al (2005) Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion–induced spinal cord injury. Ann Thorac Surg 80:2242–2249
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sarkaki, A., Rashidi, M., Ranjbaran, M. et al. Therapeutic Effects of Resveratrol on Ischemia–Reperfusion Injury in the Nervous System. Neurochem Res 46, 3085–3102 (2021). https://doi.org/10.1007/s11064-021-03412-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-021-03412-z